Rigetti Computing Is Down 70% From Its High. Time to Buy?

Rigetti Computing’s 2025 revenue fell 34% to $7.1 million as a delayed 108-qubit Cepheus-1 launch and a paused government contract reauthorization weighed on results, while the company posted a $216 million loss and negative free cash flow of $77 million. Analysts expect a sharp rebound, with revenue growth forecast at 219% this year and 103% in 2027, but the stock still screens as highly speculative with a P/S ratio above 730 and no earnings-based valuation.

Analysis

The market is still treating RGTI like an option on a narrative reset, but the real driver is whether delayed commercialization can compress the gap between hype and cash burn before dilution becomes the dominant variable. In a name with no earnings and extreme sales multiples, the stock can rerate violently on small execution wins, but that rerating is fragile because each quarter of missed delivery forces investors to underwrite more runway risk rather than more operating leverage.

The better second-order read is that any credible product or contract acceleration could help the entire quantum complex in the near term by validating the category, but the benefits likely accrue more to the highest-balance-sheet names than to the most theoretically advanced one. For RGTI specifically, improvement in revenue trajectory may actually invite selling into strength: the market is likely to fade the move unless it sees sustained bookings, not just a one-quarter catch-up from a delayed launch.

The key risk over the next 3-9 months is capital structure drift. Even with liquidity today, persistent negative free cash flow in a high-rate environment means the company will eventually be priced off financing optionality, not technology optionality, if execution does not materially inflect. That creates a path where the stock can rally on headline growth and still underperform on a 6-12 month basis if dilution expectations rise.

Consensus may be underestimating how much of the bull case is already embedded in the move from the prior spike. A 200%+ revenue rebound sounds dramatic, but off a tiny base it does little to justify the current valuation unless margins improve faster than analysts expect. The cleaner trade is not to chase the absolute upside story, but to express a view on execution dispersion: if the company is right, the stock can work; if it is merely less bad, the multiple still looks too rich.

Key Decisions for Investors

• Avoid initiating a fresh outright long in RGTI at current levels; wait for either a post-earnings drawdown or confirmation of two consecutive quarters of execution before considering exposure. Risk/reward is poor until the market has evidence that growth is recurring rather than catch-up driven.
• If expressing bullish exposure, use limited-risk call spreads in RGTIW or RGTI 6-12 months out, sized small. This keeps upside convexity to a rerating while capping downside from dilution or another product slip.
• Pair trade: long a larger, better-capitalized quantum/compute platform beneficiary against short RGTI over 3-6 months. The idea is to capture category validation while avoiding the weakest balance-sheet profile in the group.
• For hedged event risk, consider selling upside into strength via covered calls or call overwrites after sharp rallies, especially into product-update windows. The stock’s history suggests news-driven spikes are prone to mean reversion unless backed by sustained bookings.
• Monitor cash burn relative to liquidity each quarter; if free cash flow remains deeply negative and revenue ramps are back-ended, treat that as a short/setup signal rather than a turnaround signal. The trade turns from technology optionality to financing-risk optionality quickly.